A pharmacodynamic study of clopidogrel in chronic hemodialysis patients.
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Journal of Thrombosis and Thrombolysis
- Vol. 10 (2) , 127-131
- https://doi.org/10.1023/a:1018758308979
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A Clinical Trial Comparing Three Antithrombotic-Drug Regimens after Coronary-Artery StentingNew England Journal of Medicine, 1998
- ClopidogrelDrugs, 1997
- Novel Antithrombotic Drugs in DevelopmentDrugs, 1995
- Clinical Pharmacokinetics of TiclopidineClinical Pharmacokinetics, 1994
- Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosisThrombosis Research, 1991
- Intimal fibromuscular hyperplasia at the venous anastomosis of PTFE grafts in hemodialysis patients. Clinical, immunocytochemical, light and electron microscopic assessment.Circulation, 1989
- Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADPThrombosis Research, 1987
- TiclopidineDrugs, 1987
- Compared effects of three dose-levels of ticlopidine on platelet function in normal subjectsThrombosis Research, 1979